1、投稿方式：在线投稿。

2、刊内网址：（202504期）

http://www.jbr-pub.org.cn

投稿系统：

https://mc03.manuscriptcentral.com/jbrint

3、刊内邮箱：jbr@njmu.edu.cn

4、刊内电话：025-86869291

5、出刊日期：双月刊，逢单月28日出版。

2025年8月21日星期四

Instructions for Authors

【2025年01期信息】

Aim and Scope

Journal

of Biomedical Research (JBR), a peer-reviewed open-access publication

without any charges throughout the submission,review, and publication

processes, intends to provide international biomedical investigators and

clinicians with an open forum to disseminate important new information

in all aspects of experimental and clinical medicine. The Journal is

indexed by PubMed,Scopus, Web of ScienceTM Emerging Sources Citation

Index (ESCI), Google Scholar, Chemical Abstracts, and CSCD-C, and

welcomes submissions from authors worldwide. Six issues annually feature

high-quality Original Articles, Review Articles (mainly invited), Case

Reports, Letter to the Editor, and Perspectives. Manuscripts with

clinical and public health implications and manuscripts with innovative

ideas and/or approaches that bridge different fields are considered with

priority.

General Requirements

All

submitted manuscripts should contain original research that has not

been previously published partly or in full in print or electronic

format and is currently not under consideration for publication

elsewhere. Manuscripts from any country are welcome but must be written

in English. Original Articles should summarize results of a complete,

rigorously designed study supported by experimental and/or clinical data

with a thorough analysis. The recommended length for a full-length

article is 3 000 to 5 000 words, excluding abstract, references, tables,

or figures. Case Reports are intended to shed light on unusual cases

and promote knowledge about unknown or novel disease processes or

manifestations, which help contribute to a better understanding of such

diseases, or provide up-to-date knowledge about rare and uncommon

diseases. Submissions should not normally exceed 2 000 words or three

published pages including figures, diagrams, and references. Letter to

the Editor is usually written to report original data, comment on a

current controversial issue or express the viewpoint of the writer, and

it should be limited to 2 000 words. A single Figure or Table can be

made but should contain no more than eight separate panels labeled from

(a) to (h). One Figure may be composed of multiple panels with

annotations around individual panels to make viewing easier. An abstract

and subheadings should not be included in the Letters. All letters to

the Editor are subject to editing and possible abridgment. Perspectives

are intended to highlight recent, exciting research or discuss a timely

topic. They usually do not discuss the author's own work in detail, but

provide forward- looking and speculative thinking on the articles or hot

topics being discussed. If there is experimental data presented to

support the perspective, it is necessary to explain the data source. For

example, if citing a figure from others, it is necessary to obtain

consent from the original author and indicate the citation; if it is the

result of the author's own unpublished article, it is necessary to

indicate unpublished data. Perspectives should be no more than 2 000

words, with max 15 references and one figure or table. Editorial

Commentary is usually written and commissioned by editors from JBR,

which will summarize the current Special Issue or focus on commenting on

the article published in the current issue.

Rapid Publication

The

Journal offers rapid review and publication of studies that meet the

following criteria: (a) Manuscripts with late-breaking research or

immediate public health importance; (b) Manuscripts previously submitted

to other reputable journals but not accepted for publication will be

considered for rapid publication in JBR, if submitted with peer review

comments and corresponding revisions. Manuscripts suitable for rapid

publication will be processed in priority order.

If

you intend to submit your manuscript through the Rapid Publication

pathway, please state this in your cover letter. The editors will

carefully consider your request through an internal review. However, it

should be noted that approval for rapid publication does not guarantee

acceptance of the manuscript. For those manuscripts that do not qualify

for rapid publication, a standard review process will be conducted.

Details of Submission Requirements

A

cover letter from the corresponding author must accompany the

manuscript and should briefly describe what is known in the field, the

conceptual advances provided by and the significance of the reported

findings. The authors are encouraged to suggest appropriate reviewers

and are permitted to make a request for the exclusion of up to three

reviewers. The cover letter should state that the submitted material is

original research, has not been previously published, and has not been

submitted elsewhere while under review by JBR. For the materials (e.g.,

figures, diagrams, schemes, tables, and text), if any, reused/adapted

from the works that have been published in both print and electronic

formats elsewhere, written permission, if necessary, should be obtained

from the copyright owner and submitted with the manuscript. The cover

letter is confidential and will not be sent to the reviewers. The cover

letter should contain the names of all the authors and their complete

mailing addresses and identify the correspondence author.

......

更多详见刊内信息